Eurofins Scientific Annual Report 2014 Notification
12 March 2015 - 3:26AM
Business Wire
Regulatory News:
Eurofins Scientific (Paris:ERF) announces that its 2014 Annual
Report is now available on
http://www.eurofins.com/en/investor-relations/reports-presentations.aspx
For more information, please visit
www.eurofins.com or contact:Eurofins Investor
RelationsPhone: +32-2-766 1620E-mail: ir@eurofins.com
Notes for the editor:
Eurofins – a global leader in bio-analysisEurofins
Scientific is the world leader in food and pharmaceutical products
testing. It is also number one in the world in the field of
environmental laboratory services and one of the global market
leaders in agroscience, genomics, discovery pharmacology and
central laboratory services.
With over 17,000 staff in around 200 laboratories across 36
countries, Eurofins offers a portfolio of over 130,000 reliable
analytical methods for evaluating the safety, identity,
composition, authenticity, origin and purity of biological
substances and products. The Group provides its customers with
high-quality services, accurate results in time and expert advice
by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the data
available to the Company as of the date of publication, but no
guarantee can be made as to their validity.
Eurofins Scientific
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024